BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

824 related articles for article (PubMed ID: 18158160)

  • 1. Molecular model of an alpha-helical prion protein dimer and its monomeric subunits as derived from chemical cross-linking and molecular modeling calculations.
    Kaimann T; Metzger S; Kuhlmann K; Brandt B; Birkmann E; Höltje HD; Riesner D
    J Mol Biol; 2008 Feb; 376(2):582-96. PubMed ID: 18158160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical studies of conformational plasticity in a recombinant prion protein.
    Zhang H; Stockel J; Mehlhorn I; Groth D; Baldwin MA; Prusiner SB; James TL; Cohen FE
    Biochemistry; 1997 Mar; 36(12):3543-53. PubMed ID: 9132005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing misfolding of the prion protein by trimethylamine N-oxide.
    Bennion BJ; DeMarco ML; Daggett V
    Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural intermediates in the putative pathway from the cellular prion protein to the pathogenic form.
    Jansen K; Schäfer O; Birkmann E; Post K; Serban H; Prusiner SB; Riesner D
    Biol Chem; 2001 Apr; 382(4):683-91. PubMed ID: 11405232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probing PrPSc structure using chemical cross-linking and mass spectrometry: evidence of the proximity of Gly90 amino termini in the PrP 27-30 aggregate.
    Onisko B; Fernández EG; Freire ML; Schwarz A; Baier M; Camiña F; García JR; Rodríguez-Segade Villamarín S; Requena JR
    Biochemistry; 2005 Aug; 44(30):10100-9. PubMed ID: 16042387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-ray diffraction analysis of scrapie prion: intermediate and folded structures in a peptide containing two putative alpha-helices.
    Inouye H; Kirschner DA
    J Mol Biol; 1997 May; 268(2):375-89. PubMed ID: 9159477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward the molecular basis of inherited prion diseases: NMR structure of the human prion protein with V210I mutation.
    Biljan I; Ilc G; Giachin G; Raspadori A; Zhukov I; Plavec J; Legname G
    J Mol Biol; 2011 Sep; 412(4):660-73. PubMed ID: 21839748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expansion of the octarepeat domain alters the misfolding pathway but not the folding pathway of the prion protein.
    Leliveld SR; Stitz L; Korth C
    Biochemistry; 2008 Jun; 47(23):6267-78. PubMed ID: 18473442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling a prion protein dimer: predictions for fibril formation.
    Warwicker J
    Biochem Biophys Res Commun; 2000 Nov; 278(3):646-52. PubMed ID: 11095963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrogen/deuterium exchange mass spectrometry identifies two highly protected regions in recombinant full-length prion protein amyloid fibrils.
    Nazabal A; Hornemann S; Aguzzi A; Zenobi R
    J Mass Spectrom; 2009 Jun; 44(6):965-77. PubMed ID: 19283723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural dependence of the cellular isoform of prion protein on solvent: spectroscopic characterization of an intermediate conformation.
    Pergami P; Bramanti E; Ascoli GA
    Biochem Biophys Res Commun; 1999 Nov; 264(3):972-8. PubMed ID: 10544040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid formation by recombinant full-length prion proteins in phospholipid bicelle solutions.
    Lührs T; Zahn R; Wüthrich K
    J Mol Biol; 2006 Mar; 357(3):833-41. PubMed ID: 16466741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences between the prion protein and its homolog Doppel: a partially structured state with implications for scrapie formation.
    Nicholson EM; Mo H; Prusiner SB; Cohen FE; Marqusee S
    J Mol Biol; 2002 Feb; 316(3):807-15. PubMed ID: 11866533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PrP N-terminal domain triggers PrP(Sc)-like aggregation of Dpl.
    Erlich P; Cesbron JY; Lemaire-Vieille C; Curt A; Andrieu JP; Schoehn G; Jamin M; Gagnon J
    Biochem Biophys Res Commun; 2008 Jan; 365(3):478-83. PubMed ID: 17997980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of detergents on the secondary structures of prion protein peptides as studied by CD spectroscopy.
    Kuroda Y; Maeda Y; Sawa S; Shibata K; Miyamoto K; Nakagawa T
    J Pept Sci; 2003 Apr; 9(4):212-20. PubMed ID: 12725242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of the pathogenic conformational change of the prion protein by an attractor of low order.
    Havsteen BH
    J Theor Biol; 2004 Nov; 231(1):39-48. PubMed ID: 15363928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular modelling indicates that the pathological conformations of prion proteins might be beta-helical.
    Downing DT; Lazo ND
    Biochem J; 1999 Oct; 343 Pt 2(Pt 2):453-60. PubMed ID: 10510313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane interactions and conformational preferences of human and avian prion N-terminal tandem repeats: the role of copper(II) ions, pH, and membrane mimicking environments.
    Di Natale G; Pappalardo G; Milardi D; Sciacca MF; Attanasio F; La Mendola D; Rizzarelli E
    J Phys Chem B; 2010 Nov; 114(43):13830-8. PubMed ID: 20936829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polypeptide chain folding in the hydrophobic core of hamster scrapie prion: analysis by X-ray diffraction.
    Inouye H; Kirschner DA
    J Struct Biol; 1998; 122(1-2):247-55. PubMed ID: 9724626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural changes of the prion protein in lipid membranes leading to aggregation and fibrillization.
    Kazlauskaite J; Sanghera N; Sylvester I; Vénien-Bryan C; Pinheiro TJ
    Biochemistry; 2003 Mar; 42(11):3295-304. PubMed ID: 12641461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.